Professional
Added to YB: 2024-09-02
Pitch date: 2024-09-01
LFCR [bullish]
Lifecore Biomedical, Inc.
+39.3%
current return
Author Info
ToffCap are full-time fund managers finding undervalued opportunities and a reason why the price should (start to) move in the right direction. Sign up for their newsletter.
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Market Cap
$220.6M
Pitch Price
$4.30
Price Target
25.00 (+317%)
Dividend
N/A
Sector
Life Sciences Tools and Services
Category
turnaround
Betting on a Rebound: Why Lifecore Biomedical Could Triple in Value
LFCR: CDMO with $40-50m EBITDA potential. Recent headwinds: no sale, delayed filings, debt issues, poor guidance. But capacity ramping, filings current, new management. $15-25 price target on reasonable multiples. High demand for CDMO assets. Current price <$5 offers intriguing risk/reward.
Read full article (1 min)